119-S-1552 Journalist Public Summary

Public Summary — S. 1552: Living Donor Protection Act of 2025

A quick, plain‑English overview of what the bill does, why it matters, who’s for or against it, and what happens next.

Headline Summary: Protects living organ donors from being penalized by life, disability, or long‑term‑care insurers and makes organ‑donation surgery and recovery clearly eligible for job‑protected leave.

What It Does:

• Bars life, disability, and long‑term‑care insurers from denying, canceling, or upcharging policies just because someone donated an organ; insurers can still consider real, documented medical risks on a case‑by‑case basis.
• Clarifies that organ‑donation surgery and recovery count as a “serious health condition” under the Family and Medical Leave Act (FMLA), so eligible workers can take job‑protected leave; includes parallel updates for federal employees.
• Directs Health and Human Services to refresh public education (including organdonor.gov) within six months of enactment to explain benefits/risks of living donation and how the new protections affect insurance.

Why It Matters:

• Could remove two common worries that keep people from donating—insurance penalties and uncertainty about taking time off work.
• Aims to make living donation easier, which can shorten wait times for people who need transplants and improve health outcomes.

Who’s For It:

• Bipartisan Senate sponsors and cosponsors, led by Sen. Tom Cotton (R‑AR) with supporters including Sens. Kirsten Gillibrand, Cindy Hyde‑Smith, Ben Luján, Shelley Moore Capito, Angus King, Richard Blumenthal, Tim Kaine, Amy Klobuchar, Jeff Merkley, Sheldon Whitehouse, Chris Coons, Marsha Blackburn, Pete Ricketts, Thom Tillis, Dick Durbin, Jeanne Shaheen, Tina Smith, Ron Wyden, Mark Kelly, Jacky Rosen, and Raphael Warnock.
• Patient and transplant advocates generally favor policies that remove financial and workplace barriers for living donors.

Who’s Against It:

• No formal opposition is noted in the provided materials; however, insurers sometimes warn that limits on using medical information could raise costs if donors have higher long‑term risks.
• Some may prefer state‑by‑state regulation and question how “actual, unique, and material actuarial risks” will be defined and enforced.

What’s Next:

• As of February 26, 2026, the Senate Health, Education, Labor, and Pensions (HELP) Committee ordered the bill to be reported favorably with a substitute amendment.
• Next likely step is consideration by the full Senate. If it passes, the House would take it up; any differences would be worked out before it could go to the President for signature.

Tone: Neutral, factual, and easy to read—aimed at giving an ordinary voter a clear snapshot without insider jargon.